EMIS grows market share in community, child and mental health and secondary care

11 Jul 2014

EMIS increased its share in community, child and mental health (CCMH), community pharmacy and secondary and specialist care in 2014.

A trading update released by EMIS Group for the six months ended 30 June 2014 showed that the Group has continued to build momentum in CCMH with a full pipeline for its integrated offering and further contract wins in North Somerset, South Gloucestershire, Blackpool, Southport & Ormskirk and Leeds.

Two acquisitions – Ascribe and Digital Healthcare – completed in the second half of 2013 have also made positive contributions. There were further contract wins in hospitals and the roll-out of upgraded diabetic retinopathy software to comply with the requirements of Public Health England is almost complete.

In primary and community care, the roll-out of EMIS Web has continued in line with the GPSoC timetable. At period end, there were 3,751 live EMIS Web GP practices in England and Wales, an increase of 424 since 31 December 2013. The Group also increased its significant market share in community pharmacy, and nationally it launched a suite of integrated products enabling direct connections between pharmacists, GPs and patients.

Chris Spencer, Chief Executive of EMIS Group, said: “As well as trading in line with our expectations, the first half of 2014 was another period of encouraging progress for EMIS Group. In Primary and Community Care we remained on track for completion of the roll-out to English GPs of EMIS Web while winning a number of significant CCMH contracts. Across community pharmacy and secondary & specialist care we widened and deepened our connecting healthcare offerings.

“Along with politicians from every major party, we are committed to the vision of better, more affordable healthcare through connected software and services. EMIS Group is uniquely placed to help deliver that vision and we are confident in our outlook for the remainder of the year.”